International law firm Gowling WLG has advised Jazz Pharmaceuticals on its new 60,000 sq. ft, state-of-the-art manufacturing facility, representing an investment of over $100 million (approximately £75 million).
Gowling WLG advised Jazz Pharmaceuticals on all aspects of the transaction including tax, real estate, construction and pPlanning. The team that worked on the project was led by Simon Wood and Helen Emmerson with support from partners Paul Green (Construction), Lee Nuttall (Tax) and Ben Stansfield (Environmental), legal director Tim Sharp (Planning) and principal associate Heather Manning (Real Estate).
Simon Wood and Helen Emmerson, both Real Estate partners at Gowling WLG, said: "We're delighted to have worked with our longstanding client Jazz Pharmaceuticals on accomplishing this excellent result which will help them to achieve their growth strategy objectives. We'd also like to extend our thanks to Gordon Reynolds at Cushman & Wakefield for his expert advice and unstinting effort on the project."